|
Organizers   PLATINUM SPONSOR  Gold Sponsors         Silver Sponsor  Official Partners      Supporting Partners          Media Partners          |
SponsorsThe following are the sponsors and partners supporting the BioCapital China Summit 2009 - Beijing. Our thanks to all of these top-tier organizations for helping make this event possible. Organizers:
Since its founding in January, 2007, ChinaBio® LLC has rapidly launched a number of successful initiatives connecting China biotech with the world. With offices in Shanghai, Silicon Valley and San Diego, our team of industry experts is truly Helping China biotech become global biotech™. Beijing Pharma and Biotech Center (BPBC) is the principal health research agency of the Beijing Local Government; it is a component of Beijing Municipal Commission for Science and Technology (BMCST). Established in 1996 and initially function as the development and implementation of Beijing Government Grants Policy, BPBC serves as the focal point for advisory industrial policy, mandatory project management for government and international bridge between Chinese Biotech & Pharmaceutical Industry and the rest of the world. BPBC is composed of five divisions: Project Management, Strategy Study, Business Liaison and International Affairs, General Administration and Financial Management Divisions. www.newlife.org.cn/en
Platinum Sponsor:  The Balloch Group ("TBG") was established in 2001 by Howard Balloch (Canada's ambassador to China from 1996 to 2001). TBG has since grown from a market-entry consultancy working with North American clients in China to a leading advisory and merchant banking firm serving both domestic Chinese companies and multinational corporations. TBG was ranked as the number one boutique investment bank in China by ChinaVenture in 2008. TBG's professionals are located in Beijing, New York, Shanghai, Hong Kong, Wuhan and Hangzhou serving and investing alongside our clients in mergers and acquisitions, capital markets and direct investment transactions. www.ballochgroup.com Gold Sponsors:  Alexandria Real Estate Equities, Inc. (NYSE: ARE), Landlord of Choice to the Life Science Industry®, is the largest owner and preeminent real estate investment trust focused principally on cluster formation through the ownership, operation, management, selective redevelopment, development and acquisition of properties containing office/laboratory space. Alexandria provides high-quality environmentally sustainable real estate, technical infrastructure and services to the broad and diverse life science industry. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biopharmaceutical, medical device, product, service, and translational entities, as well as government agencies. Alexandria extends its industry-leading operational platform into Asia with world-class office/laboratory space available for lease at its flagship development in Tianjin, China beginning in late 2009. www.labspace.com
 Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website:www.lifetechnologies.com
 Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. www.merck.com
 Mingly China Growth Fund is a private equity fund formed in 2006 to make critical growth and expansion stage investments in China. The Fund Management Team and its Advisors include a collaboration of successful and experienced U.S. and Chinese investment professionals Demonstrated ability to identify sector leaders early and get closely engaged with founders Deep and growing pipeline with active processes to monitor companies, Hands-on operating experience to help transform companies, Global network of contacts to assist with technology, sales and marketing and management expertise, and Both Foreign Currency Fund and RMB Fund to meet the funding needs of various companies.www.mcgf.com.cn
 From concept to commercialization and through exit, Morrison & Foerster's global Life Sciences Group is recognized as a leading provider of comprehensive legal services to the life sciences industry and its funding sources. The unique strength of our practice is in our ability to meld hands-on scientific acumen with deep business and legal insight. With offices in Shanghai, Beijing, and Hong Kong, as well as Tokyo, Europe and across the United States, Morrison & Foerster is incomparably positioned to assist life sciences entities around the world. For more information, please visit www.mofo.com.
 Pfizer has been operating in China since the early 1980's committed to improving the health of the Chinese people and contributing to China's overall prosperity. Pfizer has built on this legacy by introducing innovative, relevant medicines and investing in doctor and patient educational programs. Furthermore, Pfizer contributes to China's scientific and medical development by including China in our global R&D projects. In recognition of the highly-skilled and talented scientists in China, Pfizer established its China Research and Development Center in Shanghai in 2005. The center is staffed with more than 200 Pfizer colleagues supporting various aspects of Pfizer's global R&D efforts. www.pfizer.com  Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past four decades, Wilson Sonsini Goodrich & Rosati has established its reputation by having an unmatched knowledge of its clients' industries and deep and long-standing contacts throughout the technology sector.www.wsgr.com
Silver Sponsor: 
OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm, with over $5 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully invested in over 100 private companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes approximately 30 experienced professionals with backgrounds in science, medicine, industry, finance and law. OrbiMed’s professionals work together using a collaborative, team-oriented approach to support our portfolio companies, which has earned OrbiMed a reputation as a capital provider of choice for life sciences companies of all stages. OrbiMed has created the first pan-Asia healthcare and life sciences-dedicated venture capital fund, with close to $200M under management. OrbiMed’s headquarters are in New York City and has offices in Shanghai and Mumbai. www.orbimed.com Official Partners:
 BayHelix is an organization of leaders of Chinese origin in the global life sciences and healthcare community. We aspire to shape the growth of the life sciences and healthcare industry around the Pacific Rim and beyond, foster and create business opportunities, supply and nurture the leaders for the community, and network and share information and experience. BayHelix is a non-profit organization and its membership is by-invitation-only. www.bayhelix.org
BioCentury Publications, Inc. provides essential biopharma industry intelligence from five offices in the U.S. and Europe. For more than 16 years, a global audience of biotech and pharmaceutical executives and investors has benefited from BioCentury's deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company's publications, data products and collaborative industry conferences in the U.S., Europe and Asia. BioCentury's titles include the flagship BioCentury, the Bernstein Report on BioBusiness; its SciBX: Science-Business eXchange translational science joint publishing venture with Nature Publishing Group; and its BioCentury Extra online daily newspaper. These timely journals are backed by BCIQ: BioCentury Online Intelligence,an online business intelligence resource. www.biocentury.com  Business Wire is a trusted partner to thousands of Health, Medical, Biotech and Pharmaceutical companies and organizations throughout the world, delivering more corporate news releases from more sources to more destinations than any other service. Business Wire's news wire circuits enable you to target your news to select audiences based on your geographic and industry market needs. Business Wire is the only commercial news wire with full-carriage access to all of the world's leading news agencies, including the Associated Press, Agence France-Presse, Dow Jones, Reuters, Jiji Press, Interfax and more. We can send your news to virtually any media market in the world with distribution to more than 150 countries in dozens of local languages. From delivery to audiences in a single city to comprehensive worldwide coverage including translations, Business Wire offers you an easy, one-stop solution. www.businesswire.com  goBalto is an online service that enables users to find, evaluate and manage drug development and manufacturing services providers such as Clinical Research Organizations ("CROs") and Contract Manufacturing Organizations ("CMOs") from all over the world (www.goBalto.com). Through our exclusive relationship with goBalto, ChinaBio has provided goBalto with our database of China-based CROs and CMOs. ChniaBio provides CRO/CMO selection and management services, to help companies ensure that they partner with a CRO/CMO that will meet their requirements and provide high quality data and product.
www.goBalto.com
 Since 1969, Kidder Mathews has built a reputation of integrity and is known for focusing on delivering results that meet and often exceed client expectations. Over the years, Kidder Mathews has grown from a niche company to the acknowledged regional leader in providing a full spectrum of commercial real estate services. Services offered include brokerage, appraisal, property management, consulting, and project & construction management services. GVA Kidder Mathews facilitates $2.2 billion in commercial real estate transactions each year, and currently manages a property portfolio encompassing more than 22.6 million square feet. www.gvakm.com
Supporting Partners:  Hong Kong Science and Technology Parks Corporation (HKSTP) is a statutory body set up by the Government of the Hong Kong SAR to promote and facilitate the transformation of Hong Kong into Asia’s hub for technology innovation. The Corporation supports a number of technology industries engaging in cutting-edge research and development, including the Life Science and Biotechnology industries, and offers a comprehensive range of facilities and services to address the needs of companies at various stages of development. www.hkstp.org Shanghai Pudong Bio Industry Association (SPBIA), officially founded on September 12, 2002, is serving as a social group registered in Pudong New Area. According to “The Registration and Management Principal for Social Groups”, it will recruit voluntary members from enterprises, research institutes, colleges of medicine and individuals who works in bio-pharmaceutical industry. It is also the registered legal entity approved by the Bureau of Civil Administration of Pudong New Area. Its superior management unit is the Scientific and Technological Association of Pudong New Area.
 The Shanghai Pharma Engine has been largely responsible for the launch of the early stage biotech industry in Shanghai. They operate an incubator in the Zhangjiang Hi-Tech Park located next to ChinaBio's offices with 45 biotech startups housed in two buildings, and they are adding facilities for an additional 100 companies in the next year. The ChinaBio? Accelerator recently signed a collaboration agreement with the Pharma Engine where ChinaBio? will identify co-investment opportunities in the Park and Pudong New Area.www.pharma-engine.com/EN/
Beijing Pharma and Biotech Center (BPBC) is the principal health research agency of the Beijing Local Government; it is a component of Beijing Municipal Commission for Science and Technology (BMCST). Established in 1996 and initially function as the development and implementation of Beijing Government Grants Policy, BPBC serves as the focal point for advisory industrial policy, mandatory project management for government and international bridge between Chinese Biotech & Pharmaceutical Industry and the rest of the world. BPBC is composed of five divisions: Project Management, Strategy Study, Business Liaison and International Affairs, General Administration and Financial Management Divisions. www.newlife.org.cn/en
 ChinaSF is an economic development platform supporting business exchange between China and San Francisco. It is a partnership between the City of San Francisco Mayor's Office and the San Francisco Center for Economic Development. With an office in Shanghai and in San Francisco, it is able to provide bi-lingual cross-border support to Chinese businesses interested in expanding business operations to North America. In particular, it can connect Chinese businesses to necessary professional service resources, business partners and can help navigate government regulations. This initiative builds on the already strong cultural exchange between San Francisco and China by providing a systematic support for strengthening business and economic relations.www.sfced.org/international/chinasf
 BIOCOM is a leading biotechnology industry association with over 550 leading life science companies from Southern California as members. BIOCOM's initiatives focus on capital formation, public policy, resource development and scientific discovery and development. They have recently launched a special program to educate and connect U.S.-based life science companies with low cost resources and services available in China. www.biocom.org
 Chinese-American BioPharmaceutical Society (CABS) is a not-for-profit, non-political, non-religious professional organization headquartered in San Francisco, California. With the rapid development of bio/pharmaceutical industry in China, more and more people, regardless of their ethnic backgrounds, are looking toward China for business and scientific opportunities. Recognizing this trend, CABS was established not only to educate the public with the progress in biotech and pharmaceutical fields, but also to serve the Bio/Pharmaceutical professionals who are either with Chinese heritage or with professional interests in China. The majority of CABS members are Chinese scientists, entrepreneurs and students/postdocs in biomedical sciences, working in San Francisco Bay Area bio/pharmaceutical industries, universities, and research institutes. The CABS membership is open to the public.
 The Chinese Biopharmaceutical Association (CBA) is a non-profit organization made up of professionals who have an interest in bio-pharmaceutical research and/or technology development. CBA was established in 1995 and its headquarters are located in the State of Maryland, which is adjacent to the U.S. capital city of Washington D.C. The majority of CBA members are Chinese scientists, researchers, or professors. They work in government agencies, universities, research institutes as well as in the biotechnology and pharmaceutical industries. Some are conducting pioneering research with the National Institutes of Health (NIH), whereas others are directly involved in the government regulatory process as officers of the Food and Drug Administration (FDA) or in the field of intellectual property as patent attorneys or as patent examiners with the Patent and Trademark Office (PTO).http://www.cba-usa.org/cba_home.htm
Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) is a 501(C) (3) nonprofit organization founded in early 2002 by professionals and scholars from local Chinese community in San Diego. We invite all scholars, students and professionals with any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry to join us as members of SABPA. www.sabpa.org/web/index.php
 The Sino-American Pharmaceutical Professionals Association (SAPA) was founded in 1993 as a non-profit organization with its headquarters in the Greater New York area (NJ/NY/CT). SAPA has grown rapidly to become one of the most active and well-recognized professional organizations in the United States with over 4000 members. SAPA's missions are to facilitate the advancement of pharmaceutical science and biotechnology, to contribute to public health education, to foster personal and professional career development, and to promote scientific exchange and business cooperation between the USA and China. In addition to the Greater New York area, SAPA has established regional chapters in New England (SAPA-NE), Greater Philadelphia (SAPA-GP) and West Coast (SAPA-WEST), as well as Shanghai Club (SAPA-Shanghai). www.sapaweb.org
 Guangzhou Biotechnology Center (namely Biomedical work group of Guangzhou Municipal Government) under the jurisdiction of the Biotechnology Steering Group and the Sciences &Technology Bureau of Guangzhou Municipal Government is a service agency specializing in biotechnology and medicine industry. Its key missions are to develop the biotechnology and medicine industry of Guangzhou and to accelerate the transfer of S&T achievements and parallel cooperation and exchange. www.gzbio.net
Media Partners: GB focuses exclusively on the pharmaceutical, healthcare, and biotechnology industries in China. With an understanding of ongoing policy shifts, a global perspective, and a granular knowledge of China’s players and practices, GB maintains a substantial advantage over diversified consulting firms. www.generalbiologic.com
 Bioon are the leading life science portal in China. And professional registered members have more than 500 thousand; special 70% members are the master's -and doctoral qualifications. Our enterprises’ customers are more than 11 thousand, such as Invitrogen, Promega, Qiagen, Sigma, Pall. As the leading service- provider in China, we are committed to enhance the competition of our customers in life sciences. The following pipelines are our mature businesses: (1) www.bioon.com commitment to the field of life sciences media and brand promotion; (2) www.bioon.com.cn focused on our customers’ products -promotion, display and rankings, such as equipments, consumables, reagents and antibodies; Addition, we collected and sorted the serial of databases -including China lab database, professor database and region -based registered members database. These databases are the strong support and tool for customers marketing activity and marketing survey & analysis. Now, Bioon.com has become the preferred options to life sciences’ customers for professional seminar & training, targeting product promotion, brand -improvement and marketing survey & analysis. of professional customers in China. www.bioon.com
 PharmAsiaNews.com is an online portal providing news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and other nations of the Pacific Rim. PharmAsiaNews.com leverages the editorial excellence of "The Pink Sheet" -- the leading information source for the U.S. pharmaceutical industry since 1939. Subscribers get original on-the-ground reporting from news bureaus across Asia, guest columns, exclusive interviews, news summaries, English translation summaries of Chinese- and Japanese-language news, and aggregated content from around the globe. Free 30-day trial.
 China Daily is one of the most authoritative providers of news and views in China. The paper has an average daily circulation of more than 300,000 in about 150 countries and regions. Two-thirds of China Daily’s worldwide readers are government officials, think-tanks and decision makers from multinational corporations. China Daily group has 11 English publications and one of the country’s top news internet portals. The website is one of the biggest English portals in Asia with more than 12 million daily hits, two-thirds of which are from overseas. China Daily’s Hong Kong edition is the only national publication in Hong Kong. 21st Century Weekly is the most-read English education weekly in China. A strategic cooperation agreement to open up China’s English educational market has been signed by China Daily and Scholastic Inc., the world’s largest publisher and distributor of children’s books. www.chinadaily.com.cn
 China is already the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology. ChinaBio® Today focuses exclusively on the rapidly evolving biotech industry in China. From our offices in Shanghai and California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market. www.chinabiotoday.com
 www.interfax.cn  VentureWire Lifescience is the venture industry’s premier source for comprehensive, accurate, daily intelligence on how health care-focused venture firms and their portfolio companies are gaining traction, creating value and finding exits in today’s complicated marketplace. Leveraging the global reporting acumen of Dow Jones, this extraordinary e-newsletter delivers right to your inbox every business morning:
· Breaking News – Comprehensive news and analysis of pipeline developments, FDA rulings, licensing and partnership agreements, open and closed deals, and more.
· Strategic Insights – FIRST notice of current deals, future financing plans, burn rates, valuations, forward market trends … days, even weeks, ahead of other sources (yes, even the free ones)!
· In-Depth Trend Analysis – Exclusive reporting about what’s really happening—and why—with venture capital fund-raising, investment, liquidity, deal terms, compensation, and other key areas.
· Personnel Updates – Advance warning of key executive moves, board-level changes, CEO hirings and firings, new partners and available positions. www.venturecapital.dowjones.com
 Pharma Connections Worldwide® is the leading professional business networking website focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled with the right clientele in order to facilitate business development opportunities among industry professionals responsible for making key decisions in a global marketplace. www.pharmaconnections.com
|
Copyright © 2010, ChinaBio® LLC - ChinaBio is a registered trademark of ChinaBio LLC